- Home
- HUIZ vs CLRB Comparison
HUIZ vs CLRB Comparison
Compare HUIZ & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- CLRB
- Stock Information
- Founded
- HUIZ 2006
- CLRB 2002
- Country
- HUIZ China
- CLRB United States
- Employees
- HUIZ N/A
- CLRB N/A
- Industry
- HUIZ Specialty Insurers
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- CLRB Health Care
- Exchange
- HUIZ Nasdaq
- CLRB Nasdaq
- Market Cap
- HUIZ 18.8M
- CLRB 17.6M
- IPO Year
- HUIZ 2020
- CLRB N/A
- Fundamental
- Price
- HUIZ N/A
- CLRB $5.03
- Analyst Decision
- HUIZ Hold
- CLRB Hold
- Analyst Count
- HUIZ 1
- CLRB 2
- Target Price
- HUIZ $2.30
- CLRB N/A
- AVG Volume (30 Days)
- HUIZ 18.5K
- CLRB 278.7K
- Earning Date
- HUIZ 06-06-2025
- CLRB 08-12-2025
- Dividend Yield
- HUIZ N/A
- CLRB N/A
- EPS Growth
- HUIZ N/A
- CLRB N/A
- EPS
- HUIZ N/A
- CLRB N/A
- Revenue
- HUIZ $168,454,627.00
- CLRB N/A
- Revenue This Year
- HUIZ $11.94
- CLRB N/A
- Revenue Next Year
- HUIZ $8.15
- CLRB N/A
- P/E Ratio
- HUIZ N/A
- CLRB N/A
- Revenue Growth
- HUIZ 1.28
- CLRB N/A
- 52 Week Low
- HUIZ $1.50
- CLRB $4.36
- 52 Week High
- HUIZ $10.58
- CLRB $94.50
- Technical
- Relative Strength Index (RSI)
- HUIZ 42.00
- CLRB 32.91
- Support Level
- HUIZ $1.97
- CLRB $4.36
- Resistance Level
- HUIZ $2.12
- CLRB $8.30
- Average True Range (ATR)
- HUIZ 0.10
- CLRB 1.28
- MACD
- HUIZ -0.01
- CLRB -0.72
- Stochastic Oscillator
- HUIZ 5.80
- CLRB 4.81
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.